CY1110718T1 - Ανοσογονες λιποσωμικες συνθεσεις - Google Patents

Ανοσογονες λιποσωμικες συνθεσεις

Info

Publication number
CY1110718T1
CY1110718T1 CY20101100715T CY101100715T CY1110718T1 CY 1110718 T1 CY1110718 T1 CY 1110718T1 CY 20101100715 T CY20101100715 T CY 20101100715T CY 101100715 T CY101100715 T CY 101100715T CY 1110718 T1 CY1110718 T1 CY 1110718T1
Authority
CY
Cyprus
Prior art keywords
immunous
liposome compositions
antigenic
lipid
forming
Prior art date
Application number
CY20101100715T
Other languages
English (en)
Inventor
Gary Fujii
Donald V Cramer
William A Ernst
Jill Adler-Moore
L Jeanne Perry
Original Assignee
Molecular Express Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Express Inc. filed Critical Molecular Express Inc.
Publication of CY1110718T1 publication Critical patent/CY1110718T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μια ανοσογόνο λιποσωμική σύνθεση η οποία περιλαμβάνει λιπίδια που σχηματίζουν και μια αντιγονική κατασκευή η οποία περιλαμβάνει έναν ή περισσότερους αντιγονικούς καθοριστές και έναν υδρόφοβο τομέα.
CY20101100715T 1998-09-22 2010-07-30 Ανοσογονες λιποσωμικες συνθεσεις CY1110718T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21
EP99969329A EP1115382B1 (en) 1998-09-22 1999-09-22 Immunogenic liposome compositions

Publications (1)

Publication Number Publication Date
CY1110718T1 true CY1110718T1 (el) 2015-06-10

Family

ID=26798150

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100715T CY1110718T1 (el) 1998-09-22 2010-07-30 Ανοσογονες λιποσωμικες συνθεσεις

Country Status (31)

Country Link
EP (1) EP1115382B1 (el)
JP (1) JP2002526436A (el)
KR (1) KR100592825B1 (el)
CN (1) CN1555254A (el)
AP (1) AP2010A (el)
AT (1) ATE468108T1 (el)
AU (1) AU766772B2 (el)
BG (1) BG65675B1 (el)
BR (1) BR9914004A (el)
CA (1) CA2344173C (el)
CY (1) CY1110718T1 (el)
CZ (1) CZ20011013A3 (el)
DE (1) DE69942393D1 (el)
DK (1) DK1115382T3 (el)
EA (1) EA004797B1 (el)
EE (1) EE200100168A (el)
ES (1) ES2345695T3 (el)
GE (1) GEP20053444B (el)
HK (1) HK1039064A1 (el)
HU (1) HUP0105391A3 (el)
ID (1) ID29082A (el)
IL (2) IL141675A0 (el)
MX (1) MXPA01002973A (el)
NO (1) NO330685B1 (el)
NZ (2) NZ510442A (el)
OA (1) OA11657A (el)
PL (1) PL206260B1 (el)
SK (1) SK287670B6 (el)
UA (1) UA75327C2 (el)
WO (1) WO2000016746A2 (el)
ZA (1) ZA200101829B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006235507B2 (en) 2005-04-12 2012-08-30 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
EA034702B1 (ru) * 2011-04-26 2020-03-10 Молекулар Экспресс, Инк. Липосомные композиции
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
WO2018187515A1 (en) * 2017-04-04 2018-10-11 Avidea Technologies, Inc. Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
DE3776966D1 (de) * 1986-05-20 1992-04-09 Wako Pure Chem Ind Ltd Funktionelle gruppen tragende liposome und verfahren zu deren herstellung.
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
NO20011406L (no) 2001-04-24
CA2344173A1 (en) 2000-03-30
WO2000016746A8 (en) 2000-08-10
EE200100168A (et) 2002-06-17
WO2000016746A3 (en) 2000-11-23
WO2000016746A9 (en) 2000-09-21
SK287670B6 (sk) 2011-05-06
NO330685B1 (no) 2011-06-06
PL348604A1 (en) 2002-06-03
HUP0105391A3 (en) 2006-02-28
GEP20053444B (en) 2005-02-25
DK1115382T3 (da) 2010-09-06
OA11657A (en) 2004-12-08
BG65675B1 (bg) 2009-06-30
KR100592825B1 (ko) 2006-06-23
HUP0105391A2 (hu) 2002-05-29
ID29082A (id) 2001-07-26
AP2001002096A0 (en) 2001-03-31
MXPA01002973A (es) 2003-03-27
IL141675A0 (en) 2002-03-10
EP1115382B1 (en) 2010-05-19
NO20011406D0 (no) 2001-03-20
BG105372A (en) 2001-10-31
UA75327C2 (en) 2006-04-17
KR20010075261A (ko) 2001-08-09
NZ510442A (en) 2003-10-31
HK1039064A1 (en) 2002-04-12
IL141675A (en) 2007-06-17
JP2002526436A (ja) 2002-08-20
AU6035199A (en) 2000-04-10
ATE468108T1 (de) 2010-06-15
CZ20011013A3 (cs) 2002-03-13
WO2000016746A2 (en) 2000-03-30
DE69942393D1 (de) 2010-07-01
BR9914004A (pt) 2001-07-24
CA2344173C (en) 2010-02-23
EA200100269A1 (ru) 2001-12-24
SK3222001A3 (en) 2001-09-11
ZA200101829B (en) 2002-06-05
EP1115382A2 (en) 2001-07-18
EA004797B1 (ru) 2004-08-26
AU766772B2 (en) 2003-10-23
PL206260B1 (pl) 2010-07-30
CN1555254A (zh) 2004-12-15
NZ528055A (en) 2005-01-28
AP2010A (en) 2009-06-29
ES2345695T3 (es) 2010-09-29

Similar Documents

Publication Publication Date Title
CY1110718T1 (el) Ανοσογονες λιποσωμικες συνθεσεις
ES2173284T3 (es) Agentes endoparasicitidas.
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
DZ2026A1 (fr) Compositions vaccinantes.
DE69723234D1 (de) Silikonemulsionen enthaltende wäschewaschmittelzusammensetzungen
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
CY1105896T1 (el) Χρησιμοποιηση ιδεβενονης δια την προστασια σκευασματων
DE60010098D1 (de) 28-epirapaloge
CY1105009T1 (el) Συνθεση καχαλαλιδης f
FR2765479B1 (fr) Composition lavantes et conditionnantes a base de silicone et de gomme de galactomannane hydrophobe
DE69902964D1 (de) Motorisch angetriebener Generator
ITRM20000520A0 (it) Formulazione cosmetica.
DZ2283A1 (fr) Composition de vaccin.
DE69926456D1 (de) Aminofunktionelle Siliconemulsion
DE69938555D1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
ATE252920T1 (de) Festigungsvorrichtung
DE69704696T2 (de) Organopolysiloxan-Zusammensetzungen
BR0110577A (pt) Decorina transgenicamente produzida
DE60025494D1 (de) Epothilon zusammensetzungen
DE69715951T2 (de) Dispergierbare Siliconzusammensetzungen
DE69930644D1 (de) Herstellung von polyethylen
NO20005548D0 (no) Mykobakterieinhibitorer
KR970061277A (ko) 향기발생장치
CR6332A (es) Composiciones de liposomas inmunogenicos
BR9804596B1 (pt) composiÇço cosmÉtica bifÁsica.